IGC Pharma (IGC) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IGC is expected to report earnings to rise 50.00% to -2 cents per share on February 12

Q4'24

Est.

$-0.03

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.01

Q1'24

Est.

$-0.04

Q4'23

Missed

by $0.05

The last earnings report on November 14 showed earnings per share of -1 cents, beating the estimate of -2 cents. With 70.27K shares outstanding, the current market capitalization sits at 27.06M.

View a ticker or compare two or three

Compare

IGC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For IGC
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in focuses on developing and commercializing a portfolio of cannabinoid based biopharmaceutical therapies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

10224 Falls Road

Phone

+1 301 983-0998

Employees

Web

https://www.igcinc.us